YESTAR HEALTH Issues Profit Warning, Anticipates Net Loss of at Least RMB 65 Million for 2025

Stock News

03/19

YESTAR HEALTH (02393) has announced that, compared to the consolidated net profit of approximately RMB 903.5 million achieved by the group for the year ended December 31, 2024, it expects to record a consolidated net loss of no less than RMB 65 million for the 2025 fiscal year. The anticipated shift from profit to a net loss for the group in the 2025 fiscal year is primarily attributable to the following factors: the one-time gain of approximately RMB 1,083.4 million recognized in the 2024 fiscal year due to the redemption of the company's priority notes due 2026 at a discount was not repeated in the 2025 fiscal year; and the group recognized impairment losses on non-financial assets during the 2025 fiscal year.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1153742075"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153742075\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1153742075?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 22:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153742075","market":"fut","top_or_hot":-1,"title":"YESTAR HEALTH Issues Profit Warning, Anticipates Net Loss of at Least RMB 65 Million for 2025","media":"Stock News","content":"<p>YESTAR HEALTH (02393) has announced that, compared to the consolidated net profit of approximately RMB 903.5 million achieved by the group for the year ended December 31, 2024, it expects to record a consolidated net loss of no less than RMB 65 million for the 2025 fiscal year. The anticipated shift from profit to a net loss for the group in the 2025 fiscal year is primarily attributable to the following factors: the one-time gain of approximately RMB 1,083.4 million recognized in the 2024 fiscal year due to the redemption of the company's priority notes due 2026 at a discount was not repeated in the 2025 fiscal year; and the group recognized impairment losses on non-financial assets during the 2025 fiscal year.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>YESTAR HEALTH Issues Profit Warning, Anticipates Net Loss of at Least RMB 65 Million for 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYESTAR HEALTH Issues Profit Warning, Anticipates Net Loss of at Least RMB 65 Million for 2025\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-03-19 22:56</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>YESTAR HEALTH (02393) has announced that, compared to the consolidated net profit of approximately RMB 903.5 million achieved by the group for the year ended December 31, 2024, it expects to record a consolidated net loss of no less than RMB 65 million for the 2025 fiscal year. The anticipated shift from profit to a net loss for the group in the 2025 fiscal year is primarily attributable to the following factors: the one-time gain of approximately RMB 1,083.4 million recognized in the 2024 fiscal year due to the redemption of the company's priority notes due 2026 at a discount was not repeated in the 2025 fiscal year; and the group recognized impairment losses on non-financial assets during the 2025 fiscal year.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1222","symbol_name":"醫療保健用品","start_time":0,"source_url":"","article_id":"1153742075","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153742075","pubTimestamp":1773932177,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"YESTAR HEALTH (02393) has announced that, compared to the consolidated net profit of approximately RMB 903.5 million achieved by the group for the year ended December 31, 2024, it expects to record a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1222":"医疗保健用品","02393":"巨星医疗控股"},"translate_title":"巨星健康发布盈利预警预计2025年净亏损至少6500万元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02393":1},"content_text":"YESTAR HEALTH (02393) has announced that, compared to the consolidated net profit of approximately RMB 903.5 million achieved by the group for the year ended December 31, 2024, it expects to record a consolidated net loss of no less than RMB 65 million for the 2025 fiscal year. The anticipated shift from profit to a net loss for the group in the 2025 fiscal year is primarily attributable to the following factors: the one-time gain of approximately RMB 1,083.4 million recognized in the 2024 fiscal year due to the redemption of the company's priority notes due 2026 at a discount was not repeated in the 2025 fiscal year; and the group recognized impairment losses on non-financial assets during the 2025 fiscal year.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}